We are investigating Array BioPharma Inc. (ARRY) regarding its sale to Pfizer Inc. Under the terms of the proposed agreement, each share of Array common stock will be converted into the right to receive $48.00 per share.
We are investigating Array BioPharma Inc. (ARRY) regarding its sale to Pfizer Inc. Under the terms of the proposed agreement, each share of Array common stock will be converted into the right to receive $48.00 per share.